Beate Kälz

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 4 EPO patents. Top assignee: Sanochemia Pharmazeutika Ag. Active years: 2007-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Beate Kälz. Retrieved from https://idiyas.com/inventor/beate-kalz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 1)

% Patents Active = 75.0

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 10(Granted Patents)

Company Filing History:

8 out of 15

Sanochemia Pharmazeutika Ag

patents

Years Active: 2007-2019

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10201609 - Method for the production of a formulation of a hypericin salt (2019-02-12),

2. 10143751 - Photodynamic therapy, formulation usable for this purpose, and method for the production and use thereof (2018-12-04),

3. 9775900 - Photodynamic diagnosis, formulations usable as photosensitizers for this purpose, method for the production and use thereof (2017-10-03),

4. 9629932 - Photodynamic diagnosis, formulations usable as photosensitizers for this purpose, method for the production and use thereof (2017-04-25),

5. 9315480 - Compositions of tolperisone (2016-04-19),

6. 8372979 - Process for the production of high-purity 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredient formulations that contain tolperisone (2013-02-12),

7. 7385060 - Method for producing salts of tolperisone (2008-06-10),

8. 7166588 - Derivatives and analogs of galanthamine (2007-01-23),

Title: Beate Kälz: Innovator in Photodynamic Therapy

Introduction

Beate Kälz is a prominent inventor based in Steinbrunn, Austria. She has made significant contributions to the field of photodynamic therapy, particularly in the treatment and diagnosis of tumors. With a total of 8 patents to her name, her work has the potential to impact cancer treatment methodologies.

Latest Patents

Among her latest patents is a method for the production of a formulation of a hypericin salt. This innovative approach focuses on photodynamic therapy for tumors, such as bladder tumors, utilizing a photosensitizer that is a complex or compound of hypericin and a polymeric complexing agent. The photosensitizer is derived from an alkali salt of hypericin, specifically sodium or potassium salt, combined with a complexing agent like polyethylene glycol or poly-N-vinyl amide. Another notable patent involves photodynamic diagnosis, which employs a formulation containing sodium hypericinate bonded to polyvinylpyrrolidone for the early detection of bladder cancer.

Career Highlights

Beate Kälz is currently associated with Sanochemia Pharmazeutika AG, where she continues to advance her research and development efforts in the pharmaceutical field. Her work is characterized by a commitment to improving cancer treatment options through innovative formulations and methodologies.

Collaborations

She collaborates with esteemed colleagues such as Stefan Welzig and József Gungl, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Beate Kälz stands out as a key figure in the realm of photodynamic therapy, with her patents reflecting a dedication to enhancing cancer treatment. Her contributions are paving the way for new therapeutic approaches that could significantly benefit patients in the future.

Profile summary based on public USPTO records.